2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC916
Submitter : Mr. Adam McManus Date & Time: 10/27/2005 08:10:36
Organization : Mr. Adam McManus
Category : Individual Consumer
Issue Areas/Comments
Please do not promote an abortifacient morning after pill which is harmful to the child in the womb and the woman as well.